e a single dose over 4-5 minutes, avoid rapid administration.

Infuse via a controlled infusion device at a rate d

Controls severe pain

Medication Administration

Evaluation of Medication
Effectiveness

void
S depressants,
tasks requiring
sedatives,
alertness
barbituates,
until response
benzodiazepines,
to drug is known
and tricyclic
since morphine
antidepressants
may cause
potentiate
drowsiness,
CNS dizzines
depress

Medication/Food Interactions
Client Education

Hypersensitivity to morphine or opiate agonists; convulsive disorders; acute or severe bronchial asth

Contraindications

dministering drug. Respirations of 12/min or below and miosis are signs of toxicity. Withhold drug and report t

Hypersensitvity, sweating, skeletal muscle faccidity, cold and clammy skin, hypothermia, euphoria, insomni

Adverse Efects

Nursing Interventions

Symptomatic relief of severe acute and chronic pain after non-narcotic analgesics have failed
Therapeutic Uses
PHARMALOGICA
L ACTION:
EXPECTED

Natural opium alkaloid with agonist activity that binds with the same receptors as
endogenous opioid peptides

MEDICATION Morphine IV 1-2 mg Q 4hr Prn

TOPIC DESCRIPTOR Multiple sclerosis
CONTENT

REVIEW MODULE CHAPTER

NAME Shannon Carr

Medication

ACTIVE LEARNING TEMPLATE

www.atitesting.com

2015 Assessment Technologies Institute, LLC.